Zahir H et al. |
Validation of methods to study the distribution and protein binding of tacrolimus in human blood. |
2001 Jul-Aug |
J Pharmacol Toxicol Methods |
pmid:12164257
|
van Gelder T |
Drug interactions with tacrolimus. |
2002 |
Drug Saf |
pmid:12167066
|
Zuber M and Donnerer J |
Effect of FK506 on neurotransmitter content and expression of GAP-43 in neurotoxin-lesioned peripheral sensory and sympathetic neurons. |
2002 |
Pharmacology |
pmid:12169765
|
Kapp A et al. |
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. |
2002 |
J. Allergy Clin. Immunol. |
pmid:12170269
|
Lyon CC et al. |
Topical tacrolimus in the management of peristomal pyoderma gangrenosum. |
2001 |
J Dermatolog Treat |
pmid:12171681
|
Goto M et al. |
C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation. |
2002 |
Pharmacogenetics |
pmid:12172213
|
Reinohs M et al. |
Recurrent reversible cerebral edema after long term immunosuppression with tacrolimus. |
2002 |
J. Neurol. |
pmid:12173578
|
Hardwick LL and Batiuk TD |
Severe prolonged tacrolimus overdose with minimal consequences. |
2002 |
Pharmacotherapy |
pmid:12173792
|
Walker SL et al. |
The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. |
2002 |
Br. J. Dermatol. |
pmid:12174136
|
Marsella R and Nicklin CF |
Investigation on the use of 0.3% tacrolimus lotion for canine atopic dermatitis: a pilot study. |
2002 |
Vet. Dermatol. |
pmid:12174182
|
Ebbs A et al. |
Tacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration. |
2002 |
Transplant. Proc. |
pmid:12176404
|
Savikko J et al. |
Tacrolimus inhibits platelet-derived growth factor ligand and receptor induction as well as rejection changes in rat renal allografts during long-term follow-up. |
2002 |
Transplant. Proc. |
pmid:12176405
|
Erickson L et al. |
Gene expression profiling of acute rejection and mixed lymphocyte reaction with tacrolimus immunosuppression. |
2002 |
Transplant. Proc. |
pmid:12176407
|
Wynn C et al. |
High level of TGF-beta in organ transplantation might be due to rejection rather than calcineurin inhibitor medication. |
2002 |
Transplant. Proc. |
pmid:12176408
|
Schumacher G et al. |
Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growth. |
2002 |
Transplant. Proc. |
pmid:12176410
|
Tanabe K et al. |
Synergistic effect of high-dose mizoribine and low-dose tacrolimus on renal allograft survival in nonhuman primates. |
2002 |
Transplant. Proc. |
pmid:12176425
|
Ito Y et al. |
Inhibition of epithelial replacement by nonspecific immunosuppressants accelerates rat orthotopic tracheal allograft rejection. |
2002 |
Transplant. Proc. |
pmid:12176430
|
Shibutani S et al. |
FK 506 abrogates induction of regulatory cells after intratracheal delivery of alloantigen. |
2002 |
Transplant. Proc. |
pmid:12176432
|
Stockmann M et al. |
Influence of immunosuppressive drugs on intestinal epithelial transport function. |
2002 |
Transplant. Proc. |
pmid:12176434
|
Waller JR et al. |
Effect of rapamycin in combination with calcineurin inhibitors, FK506 and cyclosporin, following arterial injury. |
2002 |
Transplant. Proc. |
pmid:12176449
|
Mayer AD |
Chronic rejection and graft half-life: five-year follow-up of the European Tacrolimus Multicenter Renal Study. |
2002 |
Transplant. Proc. |
pmid:12176452
|
Daly I et al. |
Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus. |
2002 |
Transplant. Proc. |
pmid:12176458
|
Jonas S et al. |
Cyclosporine-based quadruple induction therapy versus tacrolimus-based dual immunosuppression after liver transplantation: ten-year follow-up. |
2002 |
Transplant. Proc. |
pmid:12176459
|
Chen JW et al. |
Ten-year results of a randomised prospective study of FK506 versus cyclosporine in management of primary orthotopic liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176460
|
Figueras J et al. |
Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176461
|
Timmermann W et al. |
A randomised trial comparing the efficacy and safety of tacrolimus with microemulsified cyclosporine after liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176463
|
Hassoun Z et al. |
The choice of calcineurin inhibitor does not influence centrilobular necrosis after orthotopic liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176464
|
Oike F et al. |
Complete withdrawal of immunosuppression in living donor liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176465
|
Jain A et al. |
Steroid withdrawal under tacrolimus for primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis after liver transplantation and long-term survival. |
2002 |
Transplant. Proc. |
pmid:12176467
|
Lladó L et al. |
Prospective study of a tacrolimus-based quadruple immunosuppressive regimen: evaluation of safety and efficacy. |
2002 |
Transplant. Proc. |
pmid:12176468
|
Serrano J et al. |
Tacrolimus is effective in both dual and triple regimens after liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176469
|
Troisi R et al. |
Are reduced tacrolimus dosages needed in the early postoperative period following living donor liver transplantation in adults? |
2002 |
Transplant. Proc. |
pmid:12176470
|
Varo E et al. |
Alternative immunosuppression for acute renal failure in liver transplantation: role of ultra-low dose tacrolimus and basiliximab. |
2002 |
Transplant. Proc. |
pmid:12176471
|
Braun F et al. |
Therapeutic drug monitoring of tacrolimus early after liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176473
|
Jain AK et al. |
Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients. |
2002 |
Transplant. Proc. |
pmid:12176474
|
Junge G et al. |
Microchimerism in patients after orthotopic liver transplantation: a prognostic indicator? |
2002 |
Transplant. Proc. |
pmid:12176475
|
Böttiger Y et al. |
Effect of bile flow on the absorption of tacrolimus in liver allograft transplantation. |
2002 |
Transplant. Proc. |
pmid:12176476
|
Hodge EE et al. |
Use of mycophenolate mofetil in liver transplant recipients experiencing renal dysfunction on cyclosporine or tacrolimus-randomized, prospective, multicenter study results. |
2002 |
Transplant. Proc. |
pmid:12176477
|
Charco R et al. |
Changes in renal function in long-term survivors of liver transplantation: a comparison between cyclosporine microemulsion and tacrolimus therapy. |
2002 |
Transplant. Proc. |
pmid:12176478
|
Aguirrezabalaga J et al. |
Lipid profiles after liver transplantation in patients receiving tacrolimus or cyclosporin. |
2002 |
Transplant. Proc. |
pmid:12176480
|
Varo E et al. |
Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy. |
2002 |
Transplant. Proc. |
pmid:12176481
|
Charco R et al. |
Low incidence of hypercholesterolemia among liver transplant patients under tacrolimus monotherapy immunosuppression. |
2002 |
Transplant. Proc. |
pmid:12176482
|
Rabkin JM et al. |
Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176483
|
Langrehr JM et al. |
First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV. |
2002 |
Transplant. Proc. |
pmid:12176487
|
Varo E et al. |
Incidence of cytomegalovirus infection and disease in orthotopic liver transplant patients immunosuppressed with cyclosporin versus tacrolimus. |
2002 |
Transplant. Proc. |
pmid:12176488
|
Fukuhara N et al. |
Long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart-beating donors. |
2002 |
Transplant. Proc. |
pmid:12176492
|
Tanabe K et al. |
Outcome of kidney transplantation from non-heart-beating donors followed by tacrolimus immunosuppression in japan. |
2002 |
Transplant. Proc. |
pmid:12176493
|
Squifflet JP et al. |
Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study. |
2002 |
Transplant. Proc. |
pmid:12176495
|
Waller JR et al. |
Primary immunosuppression with tacrolimus is associated with a reduction in renal allograft fibrosis compared with neoral therapy. |
2002 |
Transplant. Proc. |
pmid:12176496
|
Miyagi M et al. |
Comparison of the therapeutic effects between CsA and FK506 on chronic renal allograft injury and TGF-beta expression. |
2002 |
Transplant. Proc. |
pmid:12176497
|
van Hooff JP et al. |
Benelux experience with a combination of tacrolimus and mycophenolate mofetil: 4-year results. |
2002 |
Transplant. Proc. |
pmid:12176498
|
Budde K et al. |
Five year outcome of tacrolimus rescue therapy in late rejection after renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176499
|
Takahara S et al. |
Excellent results following 3 years of tacrolimus immunosuppression in kidney transplantation recipients in Japan: overall analysis of more than 1000 patients. |
2002 |
Transplant. Proc. |
pmid:12176500
|
Yoshimura N et al. |
Safety analysis following tacrolimus immunosuppression in renal transplant recipients in Japan: 3-year results in over 1000 patients. |
2002 |
Transplant. Proc. |
pmid:12176501
|
Takahashi K et al. |
Successful results after 3 years' tacrolimus immunosuppression in ABO-incompatible kidney transplantation recipients in Japan. |
2002 |
Transplant. Proc. |
pmid:12176502
|
Uchida K et al. |
Excellent 3-year results following living-donor kidney transplantation and tacrolimus immunosuppression in Japan. |
2002 |
Transplant. Proc. |
pmid:12176503
|
Burke GW et al. |
Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection. |
2002 |
Transplant. Proc. |
pmid:12176505
|
Coupes BM et al. |
Tacrolimus monotherapy in renal transplantation: four-year data. |
2002 |
Transplant. Proc. |
pmid:12176506
|
Sonnenday CJ et al. |
Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match. |
2002 |
Transplant. Proc. |
pmid:12176507
|
Ciancio G et al. |
Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176508
|
Charpentier B |
A three arm study comparing immediate tacrolimus therapy with ATG induction therapy followed by either tacrolimus or cyclosporine in adult renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176511
|
Montagnino G et al. |
Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in kidney transplantation: twelve-month follow-up. |
2002 |
Transplant. Proc. |
pmid:12176515
|
Garcia I |
Efficacy and safety of dual versus triple tacrolimus-based therapy in kidney transplantation: two-year follow-up. |
2002 |
Transplant. Proc. |
pmid:12176516
|
Craig AM et al. |
A cost-effectiveness analysis of tacrolimus versus cyclosporine microemulsion following kidney transplantation. |
2002 |
Transplant. Proc. |
pmid:12176519
|
Rashid I et al. |
Medium-term outcome using sirolimus-tacrolimus combination in adult renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176520
|
Shapiro R et al. |
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176521
|
Youseff N and Small S |
A retrospective analysis of a sirolimus/prograf regimen for the prevention of acute rejection in recipients of primary mismatched renal allografts. |
2002 |
Transplant. Proc. |
pmid:12176522
|
Campos HH and Abbud Filho M |
One-year follow-up of a Brazilian randomized multicenter study comparing tacrolimus versus cyclosporine in kidney transplantation. |
2002 |
Transplant. Proc. |
pmid:12176523
|
Dietl KH |
Oral dosing of tacrolimus and cyclosporine microemulsion--results from a large multicenter study in renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176524
|
Gurkan A et al. |
Comparison of tacrolimus and neoral-based immunosuppressive regimens in renal transplantation patients: singles-center experience. |
2002 |
Transplant. Proc. |
pmid:12176525
|
Wayman MR et al. |
Two-year outcome in renal allograft recipients comparing neoral-led with tacrolimus-led therapy. |
2002 |
Transplant. Proc. |
pmid:12176526
|
Okamoto M et al. |
Tacrolimus-based immunosuppression in renal transplantation: 78 experiences in a single Japanese center. |
2002 |
Transplant. Proc. |
pmid:12176527
|
Tanabe K et al. |
Improved outcome of minor-mismatched living renal allografts under tacrolimus immunosuppression. |
2002 |
Transplant. Proc. |
pmid:12176528
|
Scolari MP et al. |
Acute rejection after renal transplantation with tacrolimus-based therapy in conditions of normal clinical practice. |
2002 |
Transplant. Proc. |
pmid:12176529
|
Ushigome H et al. |
Immunosuppression in cadaveric renal transplant recipients from non-heart-beating donors in a single center. |
2002 |
Transplant. Proc. |
pmid:12176533
|
Citterio F et al. |
Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up. |
2002 |
Transplant. Proc. |
pmid:12176535
|
Sola E et al. |
Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil. |
2002 |
Transplant. Proc. |
pmid:12176537
|
Moons P et al. |
Steroids may compromise quality of life of renal transplant recipients on a tacrolimus-based regimen. |
2002 |
Transplant. Proc. |
pmid:12176538
|
Beaunoyer M et al. |
Low-dose tacrolimus, trough-monitored mycophenolate mofetil, and planned steroid withdrawal for cadaveric kidney transplantation: a single center experience. |
2002 |
Transplant. Proc. |
pmid:12176540
|
Boots JM et al. |
Risk of adrenal insufficiency with steroid maintenance therapy in renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176541
|
Boots JM et al. |
Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study. |
2002 |
Transplant. Proc. |
pmid:12176542
|
Citterio F et al. |
Steroid withdrawal from tacrolimus-based therapy in renal transplant patients. |
2002 |
Transplant. Proc. |
pmid:12176545
|
Baran DA et al. |
Tacrolimus and new onset diabetes mellitus: the effect of steroid weaning. |
2002 |
Transplant. Proc. |
pmid:12176547
|
Rodrigo E et al. |
Histopathological findings according to Banff-97 classification system comparing tacrolimus versus cyclosporine. |
2002 |
Transplant. Proc. |
pmid:12176550
|
Jørgensen KA et al. |
Two-hour blood tacrolimus levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal transplant patients. |
2002 |
Transplant. Proc. |
pmid:12176551
|
van Duijnhoven EM et al. |
Evidence that fasting does not significantly affect trough levels of tacrolimus in stable renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176552
|
Saito K et al. |
Study of pharmacokinetic parameters of tacrolimus by different oral administration periods in renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176553
|
Sifontis NM et al. |
Clinically significant drug interaction between basiliximab and tacrolimus in renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176554
|
Toda F et al. |
Tacrolimus trough level adjustment after administration of fluconazole to kidney recipients. |
2002 |
Transplant. Proc. |
pmid:12176555
|
Uchida K et al. |
Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176556
|
Pozzetto U et al. |
Effects of immunosuppressive regimens on plasma levels of transforming growth factor-beta 1 in renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176558
|
Koefoed-Nielsen PB and Jørgensen KA |
Alterations in calcineurin phosphatase activity in tacrolimus-treated renal transplant patients. |
2002 |
Transplant. Proc. |
pmid:12176559
|
Baid S et al. |
Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis C infection. |
2002 |
Transplant. Proc. |
pmid:12176569
|
Akioka K et al. |
Diabetes in renal transplant recipients treated with tacrolimus. |
2002 |
Transplant. Proc. |
pmid:12176570
|
Artz MA et al. |
Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels. |
2002 |
Transplant. Proc. |
pmid:12176579
|
Boucher A et al. |
Impact of immunosuppressive regimen on cardiovascular risk factors in kidney transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176582
|
Suwelack B et al. |
Replacement of calcineurin inhibitors by mycophenolate mofetil: effect on hemoglobine levels. |
2002 |
Transplant. Proc. |
pmid:12176585
|
El Haggan W et al. |
One year evolution of bone mineral density in kidney transplant recipients receiving tacrolimus versus cyclosporine. |
2002 |
Transplant. Proc. |
pmid:12176589
|
Tanabe K et al. |
Prospective analysis of thrombotic microangiopathy after renal transplantation: comparison between cyclosporine and tacrolimus immunosuppression. |
2002 |
Transplant. Proc. |
pmid:12176590
|
Omoto K et al. |
Adverse events in renal transplantation under tacrolimus/mycophnolate mofetil immunosuppression: a single-center experience. |
2002 |
Transplant. Proc. |
pmid:12176591
|